Critics worry that the user fee program creates a conflict of interest between the FDA and pharmaceutical companies.

Robert F. Kennedy Jr.'s overhaul of federal health agencies will likely impact how Americans get health care, prescription drugs and more.

Generative Phosphoproteomics AP3 platform designed to enable streamlined, rational drug discovery, with proprietary, proteome-wide SAR delivering ...

MELVILLE, N.Y., March 27, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative”, "BRTX” or the "Company”) ...

An oral history project aims to document the stories of the federal workforce cuts. The project is open to all feds and ...

First approved therapy to address hyperphagia in individuals with Prader-Willi syndrome Management to host conference call and webcast today, March 26th, at 5:30pm ET REDWOOD CITY, Calif., March 26, ...

Presented a poster highlighting the use of the Company's Magellan™ drug discovery platform to identify allosteric inhibitors ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced on Thursday morning that his department would cut 10,000 jobs and merge sections to create a new "Administration for a Healthy ...

As part of this year's conference, attendees have the opportunity to receive the IDFA Advanced Leadership and Management Certificate.

You might know the melting point for glass, plastic or metal, and that they all have a specific point or range, depending on the... If you’re a business owner in Michigan, the 2025 Property and ...

Members are invited to join us for Exchange Circle Talk - Objects of Play: Hoo Mojong Centennial Retrospective at Art Basel 2025.